News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
692,093 Results
Type
Article (57678)
Company Profile (655)
Press Release (633760)
Section
Business (191557)
Career Advice (2979)
Deals (34784)
Drug Delivery (115)
Drug Development (80389)
Employer Resources (164)
FDA (17421)
Job Trends (15239)
News (335170)
Policy (35666)
Tag
Academia (2839)
Alliances (49511)
Alzheimer's disease (1342)
Approvals (17328)
Artificial intelligence (161)
Bankruptcy (336)
Best Places to Work (11918)
Biotechnology (450)
Breast cancer (193)
Cancer (1388)
Cardiovascular disease (119)
Career advice (2498)
Cell therapy (297)
Clinical research (63858)
Collaboration (464)
Compensation (250)
COVID-19 (2773)
C-suite (112)
Data (1376)
Diabetes (179)
Diagnostics (6506)
Drug pricing (107)
Earnings (73908)
Employer resources (148)
Events (106158)
Executive appointments (360)
FDA (18077)
Funding (418)
Gene therapy (216)
GLP-1 (690)
Government (4841)
Healthcare (19505)
Infectious disease (2870)
Inflammatory bowel disease (118)
Interviews (562)
IPO (16310)
Job creations (3783)
Job search strategy (2082)
Layoffs (475)
Legal (8436)
Lung cancer (201)
Manufacturing (214)
Medical device (14002)
Medtech (14007)
Mergers & acquisitions (18621)
Metabolic disorders (493)
Neuroscience (1686)
NextGen Class of 2024 (7043)
Non-profit (4661)
Northern California (1649)
Obesity (287)
Opinion (219)
Patents (123)
People (53905)
Pharmaceutical (134)
Phase I (19441)
Phase II (27836)
Phase III (21552)
Pipeline (518)
Postmarket research (2878)
Preclinical (8348)
Radiopharmaceuticals (249)
Rare diseases (281)
Real estate (6145)
Regulatory (23912)
Research institute (2525)
Resumes & cover letters (492)
Southern California (1443)
Startups (3648)
United States (15295)
Vaccines (655)
Weight loss (224)
Date
Last 7 days (713)
Last 30 days (2574)
Last 365 days (36813)
2024 (35972)
2023 (41249)
2022 (52482)
2021 (57045)
2020 (55613)
2019 (48338)
2018 (36851)
2017 (34453)
2016 (34040)
2015 (38835)
2014 (31196)
2013 (26109)
2012 (28285)
2011 (28660)
2010 (26288)
Location
Africa (948)
Arizona (175)
Asia (41303)
Australia (7199)
California (3827)
Canada (1372)
China (287)
Colorado (172)
Connecticut (190)
Europe (95987)
Florida (517)
Georgia (136)
Illinois (404)
Indiana (219)
Maryland (660)
Massachusetts (3015)
Michigan (160)
Minnesota (292)
New Jersey (1089)
New York (1057)
North Carolina (842)
Northern California (1649)
Ohio (147)
Pennsylvania (899)
South America (1322)
Southern California (1443)
Texas (544)
Washington State (416)
692,093 Results for "amplifon s p a us headquarters".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BIOSECURE Act
WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow
WuXi AppTec looks to unload its Philadelphia manufacturing sites and WuXi Biologics slows its rapid expansion in the U.S. as the companies await the Senate’s review of the BIOSECURE Act that threatens to cut them off from U.S. biopharma.
October 8, 2024
·
5 min read
·
Ben Hargreaves
Business
EMD Serono Announces Plans for New U.S. Healthcare Headquarters in Boston’s Seaport District
EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, announced that it plans to move its U.S. Healthcare headquarters, currently located in Rockland, Mass., to Boston’s Seaport district.
November 14, 2023
·
3 min read
Regulatory
Novo Secures EU Panel’s Backing for Cardiovascular Use of Wegovy
With Thursday’s positive opinion from the Committee for Medicinal Products for Human Use, the matter now heads to the European Commission which will have the final say on whether Wegovy’s label will be updated.
September 20, 2024
·
2 min read
·
Tristan Manalac
Business
Complete Genomics opens U.S. supply chain to genomic sequencing customers through a new manufacturing facility at its San Jose, Calif. headquarters
Complete Genomics, a pioneering genomic sequencing company, recently welcomed vendors, suppliers, customers and employees to a May 17 grand opening celebration of its 10,115 square foot manufacturing facility at its headquarters in San Jose, California.
May 23, 2024
·
2 min read
Press Releases
Axxam S.p.A. accelerates global expansion incorporating Axxam Inc.
December 13, 2024
·
2 min read
COVID-19
FDA Limits Use of Invivyd’s COVID-19 Prophylactic as New Variants Dominate
The regulator’s restrictions come as the U.S. is experiencing a surge in cases. Invivyd also announced updated Phase III data for Pemgarda, touting an 84% relative reduction in symptomatic COVID-19.
August 28, 2024
·
2 min read
·
Tristan Manalac
FDA
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease
Quanterix Corporation announced today that its Simoa ® phospho-Tau 217 (p-Tau 217) blood test has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA) as an aid in diagnostic evaluation of Alzheimer’s Disease (AD).
March 4, 2024
·
4 min read
Policy
Celltrion USA completes submission of Biologics License Application (BLA) to U.S. FDA for CT-P39, an interchangeable biosimilar candidate of XOLAIR® (omalizumab)
Celltrion USA announced that the company has submitted a Biologics License Application for CT-P39, an interchangeable biosimilar candidate to XOLAIR® to the U.S. Food and Drug Administration.
March 10, 2024
·
5 min read
Opinion
BIOSECURE Act Threatens Already Strained U.S. Supply Chain
As Congress considers a bill that aims to distance U.S. biopharma from five Chinese companies, the industry must emphasize the importance of prioritizing patient care over power plays.
September 9, 2024
·
3 min read
·
JX (Jaxon) Tan
Business
BAP Pharma Announces Grand Opening Ceremony for New US Headquarters in Somerset, NJ
BAP Pharma will welcome guests and dignitaries to the Grand Opening Ceremony of its new headquarters on Randolph Road with a formal ribbon cutting ceremony, speeches, and exclusive tours of the new facility.
April 17, 2024
·
2 min read
1 of 69,210
Next
